Pharma-Bio Serv, Inc. (PBSV)
OTCMKTS · Delayed Price · Currency is USD
0.5650
0.00 (0.00%)
At close: Jun 15, 2026
Pharma-Bio Serv Income Statement
Financials in millions USD. Fiscal year is November - October.
Millions USD. Fiscal year is Nov - Oct.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 31, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
| 8.82 | 9 | 9.51 | 16.98 | 19.4 | 20.12 | |
Revenue Growth (YoY) | -8.08% | -5.34% | -43.99% | -12.48% | -3.56% | -6.72% |
Cost of Revenue | 5.96 | 6.09 | 6.99 | 11.91 | 14.52 | 14.76 |
Gross Profit | 2.86 | 2.91 | 2.52 | 5.07 | 4.88 | 5.36 |
Selling, General & Admin | 3.5 | 3.55 | 3.8 | 3.95 | 3.71 | 4.01 |
Operating Expenses | 3.5 | 3.55 | 3.8 | 3.95 | 3.71 | 9.21 |
Operating Income | -0.64 | -0.64 | -1.29 | 1.12 | 1.17 | -3.85 |
Interest & Investment Income | 0.64 | 0.64 | 0.53 | - | - | - |
Currency Exchange Gain (Loss) | -0.1 | -0.1 | - | - | - | - |
Other Non Operating Income (Expenses) | 0.03 | - | - | 0.57 | 0.01 | 0.02 |
EBT Excluding Unusual Items | -0.07 | -0.09 | -0.76 | 1.69 | 1.19 | -3.83 |
Other Unusual Items | - | - | - | - | - | 1.96 |
Pretax Income | -0.07 | -0.09 | -0.76 | 1.69 | 1.19 | -1.88 |
Income Tax Expense | 0.01 | 0.01 | 0.02 | 0.38 | 0.18 | 0.21 |
Earnings From Continuing Operations | -0.08 | -0.1 | -0.78 | 1.31 | 1.01 | -2.09 |
Net Income | -0.08 | -0.1 | -0.78 | 1.31 | 1.01 | -2.09 |
Net Income to Common | -0.08 | -0.1 | -0.78 | 1.31 | 1.01 | -2.09 |
Net Income Growth | - | - | - | 30.15% | - | - |
Shares Outstanding (Basic) | 23 | 23 | 23 | 23 | 23 | 23 |
Shares Outstanding (Diluted) | 23 | 23 | 23 | 23 | 23 | 23 |
Shares Change (YoY) | -0.13% | -0.07% | -0.10% | -0.15% | -0.56% | 0.53% |
EPS (Basic) | -0.00 | -0.00 | -0.03 | 0.06 | 0.04 | -0.09 |
EPS (Diluted) | -0.00 | -0.00 | -0.03 | 0.06 | 0.04 | -0.09 |
EPS Growth | - | - | - | 30.25% | - | - |
Free Cash Flow | -0.18 | -0.22 | -0.73 | 1.88 | 0.57 | 0.79 |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.03 | 0.08 | 0.03 | 0.03 |
Gross Margin | 32.46% | 32.33% | 26.46% | 29.84% | 25.16% | 26.65% |
Operating Margin | -7.25% | -7.08% | -13.54% | 6.58% | 6.06% | -19.16% |
Profit Margin | -0.86% | -1.12% | -8.18% | 7.72% | 5.19% | -10.39% |
Free Cash Flow Margin | -2.09% | -2.46% | -7.64% | 11.10% | 2.96% | 3.95% |
EBITDA | -0.57 | -0.58 | -1.26 | 1.17 | 1.23 | -3.78 |
EBITDA Margin | -6.51% | -6.42% | -13.30% | 6.87% | 6.32% | -18.80% |
D&A For EBITDA | 0.07 | 0.06 | 0.02 | 0.05 | 0.05 | 0.07 |
EBIT | -0.64 | -0.64 | -1.29 | 1.12 | 1.17 | -3.85 |
EBIT Margin | -7.25% | -7.08% | -13.54% | 6.58% | 6.06% | -19.16% |
Effective Tax Rate | - | - | - | 22.36% | 15.29% | - |